Molecular characterisation of isoniazid-resistant Mycobacterium tuberculosis isolated from new cases in Lagunes region (Côte d'Ivoire)

International Journal of Antimicrobial Agents

Volumn 31, Issue 5, 2008, Pages 498-500

  N'Guessan, Kouassi Raymond ^a   Dosso, Mireille ^a   Ekaza, Euloge ^a   Kouakou, Jacquemin ^b   Jarlier, Vincent ^c  

^a INSTITUT PASTEUR DE CÔTE D'IVOIRE   (Côte d’Ivoire)

^b Programme National de Lutte contre la Tuberculose   (Côte d’Ivoire)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; GENE AMPLIFICATION; GENE SEQUENCE; LETTER; MOLECULAR TYPING; MUTATION RATE; MYCOBACTERIUM TUBERCULOSIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATALASE; COTE D'IVOIRE; DNA MUTATIONAL ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; HUMANS; ISONIAZID; MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASES; TUBERCULOSIS;

EID: 41949114160     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.01.008     Document Type: Letter

References (7)

1. Canetti G., Rist N., and Grosset J. Measurement of sensitivity of the tuberculous bacillus to antibacillary drugs by the method of proportions. Methodology, resistance criteria, results and interpretation. Rev Tuberc Pneumol (Paris) 27 (1963) 217-272 [in French]
2. van Soolingen D., de Haas P.E., van Doorn H.R., Kuijper E., Rinder H., and Borgdorff M.W. Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands. J Infect Dis 182 (2000) 1788-1790
3. Parsons L.M., Salfinger M., Clobridge A., Domandy J., Mirabello L., Polletta V.L., et al. Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol. Antimicrob Agents Chemother 49 (2005) 2218-2225
4. Telenti A., Imboden P., Marchesi F., Lowrie D., Cole S.T., Colston M.J., et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341 (1993) 647-650
5. Cohen T., Becerra M.C., and Murray M.B. Isoniazid resistance and the future of drug-resistant tuberculosis. Microb Drug Resist 4 (2004) 280-284
6. Brossier F., Veziris N., Truffot-Pernot C., Jarlier V., and Sougakoff W. Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance. J Clin Microbiol 44 (2006) 3659-3664
7. Baker L.V., Brown T.J., Maxwell O., Gibson A.L., Fang Z., Yates M.D., et al. Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC-46A polymorphism. Antimicrob Agents Chemother 49 (2005) 1455-1464